BMO vs MFG

The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score prevents a full solvency risk assessment. Despite solid profitability metrics like a 38.67% operating margin and strong revenue growth of 15.50%, earnings growth is inconsistent, with recent Q/Q declines and volatile quarterly surprises. The stock trades above its Graham defensive value of $127.87 at $137.69, yet below the analyst target of $127.91, while offering a solid 3.45% dividend yield with a sustainable 56.29% payout ratio. Technical trend sentiment is weak at 10/100, offsetting positive insider sentiment, resulting in a neutral overall stance.

MFG presents a stark dichotomy between poor operational health (Piotroski F-Score: 2/9) and highly attractive valuation metrics. The stock is currently trading near its Graham Number ($8.22) and significantly below its growth-based intrinsic value ($15.64). While the company demonstrates strong earnings growth (16.4% YoY) and a compelling forward P/E of 6.06, the low F-Score suggests deteriorating fundamental trends that offset the valuation appeal. Consequently, the stock is a high-value play burdened by significant internal health warnings.